Closing Bell: Medexus Pharmaceuticals Inc down on Thursday (MDP)

Medexus Pharmaceuticals Inc opened trading today at $2.17 and closed at $2.13. It traded at a low of $2.13 to a high of $2.17.

The price decreased -0.93 percent from the previous day's close of $2.15.

Today across North America, the TSX Composite closed -0.14% at 22608.03, the S&P 500 closed -2.31% at 5427.13, the Dow Jones Industrial Average closed -1.25% at 39853.87 and the Nasdaq Composite closed -3.64% at 17342.41.

Medexus Pharmaceuticals Inc traded under MDP on the Toronto Stock Exchange (TSX).

Trading volume was 5,607 on 23 total trades. On average, Medexus Pharmaceuticals Inc has traded 17,358 shares in the last five days and 49,731 year-to-date.

Trading across the entire TSX saw 3,490 price advancers against 1,736 declines and 92 unchanged.

During the prior 52 weeks, MDP.TO has traded as high as $3.53 (August 24,2023) and low as $1.44 (December 04,2023). Moreover, the shares have advanced 3.90 percent in the last year, while in 2024, they have dipped -13.77%.

Following today's trading, Medexus Pharmaceuticals Inc has a market capitalization of $52.59 million on a float of 24,459 shares outstanding. Its annual EPS is $-0.01.

Medexus Pharmaceuticals Inc is a TSX Drug Specialty & Generic company headquartered in Toronto, CAN.

Currently, Medexus Pharmaceuticals Inc's consensus rating is "Moderate Buy" based on 4 analysts according to Zacks. From those 4 analysts, 3 have buy ratings and 1 analysts gave hold ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..